Co-Founder and CEO
Scott Xiao is the Co-Founder and CEO of Luminopia, a digital therapeutics company whose lead product is a groundbreaking new treatment for lazy eye, the leading cause of vision loss in children. Working with leading clinicians at Boston Children’s Hospital and Johns Hopkins, he has developed a virtual reality (VR) based device that modifies popular TV shows and movies into therapeutic visual stimuli, making treatment both more fun and effective. The technology has been validated in several clinical trials, including a nationwide, phase 3 pivotal trial. The team received FDA approval about a year ago, becoming the first company to get FDA approval for a VR-based treatment for any medical condition, and the product is now being prescribed by the top eye institutes and children's hospitals across the US. For his work on Luminopia, Scott has been named to the Forbes 30 Under 30 list for healthcare and the MIT Technology Review Innovators Under 35.
September 20 Wednesday